The analysis was performed on independent study sets of HER2-positive and negative/low breast cancers, already analyzed by central immunohistochemistry (IHC) and FISH testing. Phospho-HER2 and ...

MammaTyperRT-qPCR与IHC检测乳腺癌ER/PR/Ki67/HER2-low之间显示出高度一致性。目前，尽管多基因检测技术在乳腺癌的诊断和治疗中扮演着越来越重要的角色，但对于这些多基因测试与免疫组织化学（IHC）结果之间相关性的数据仍然 ...

All positive (IHC 3+) and doubtful (IHC 2+) cases were screened by fl uorescence in situ hybridization (FISH). Patients with HER2 gene amplification, normal left ventricular ejection fraction ...

US FDA approves Roche’s companion diagnostic to identify patients with biliary tract cancer eligible for HER2-targeted treatment with Ziihera: Tucson, Arizona Tuesday, November ...

The FDA has granted accelerated approval to zanidatamab-hrii (Ziihera) for adult patients with previously treated, unresectable or metastatic HER2-positive (immunohistochemistry 3+) biliary tract ...